Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC Lin, CH Chiu, JL Liou, YM Chen, RP Perng… - Lung Cancer, 2006 - Elsevier
PURPOSE: This phase II single arm, open label study was designed to evaluate the efficacy
and toxicity of oral gefitinib (250mg) daily in previously untreated patients with advanced …
被引用次数：43 相关文章

Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC Lin, CH Chiu, JL Liou, YM Chen, RP Perng… - Lung …, 2006 - hub.tmu.edu.tw
Purpose: This phase II single arm, open label study was designed to evaluate the efficacy
and toxicity of oral gefitinib (250 mg) daily in previously untreated patients with advanced …

Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC Lin, CH Chiu, JL Liou, YM Chen, RP Perng… - Lung Cancer, 2006 - infona.pl
This phase II single arm, open label study was designed to evaluate the efficacy and toxicity
of oral gefitinib (250mg) daily in previously untreated patients with advanced non-small-cell …

[引用][C] Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC Lin, CH Chiu, JL Liou, YM Chen, RP Perng… - Lung Cancer, 2006 - cir.nii.ac.jp
Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

[引用][C] Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC LIN, CH CHIU, JL LIOU, YM CHEN… - Lung …, 2006 - pascal-francis.inist.fr
Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung
cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC Lin, CH Chiu, JL Liou, YM Chen… - Lung cancer …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose This phase II single arm, open label study was designed to evaluate the efficacy
and toxicity of oral gefitinib (250mg) daily in previously untreated patients with advanced …

Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC Lin, CH Chiu, JL Liou, YM Chen, RP Perng… - Lung …, 2006 - lungcancerjournal.info
Purpose This phase II single arm, open label study was designed to evaluate the efficacy
and toxicity of oral gefitinib (250mg) daily in previously untreated patients with advanced …

Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer.

WC Lin, CH Chiu, JL Liou, YM Chen… - Lung Cancer …, 2006 - europepmc.org
Purpose This phase II single arm, open label study was designed to evaluate the efficacy
and toxicity of oral gefitinib (250mg) daily in previously untreated patients with advanced …

Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC Lin, CH Chiu, JL Liou, YM Chen, RP Perng… - Lung …, 2006 - hub.tmu.edu.tw
Purpose: This phase II single arm, open label study was designed to evaluate the efficacy
and toxicity of oral gefitinib (250 mg) daily in previously untreated patients with advanced …

[引用][C] Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer

WC LIN, CH CHIU, JL LIOU, YM CHEN, RP PERNG… - Lung cancer, 2006 - Elsevier